Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chubb
Fuji
Accenture
US Army
McKinsey
Merck
Queensland Health
Daiichi Sankyo

Generated: December 18, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER

« Back to Dashboard

Clinical Trials for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container

Trial ID Title Status Sponsor Phase Summary
NCT00062231 Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer Terminated European Organisation for Research and Treatment of Cancer - EORTC N/A RATIONALE: Antibiotics such as amoxicillin, ciprofloxacin, and moxifloxacin may be effective in preventing or controlling fever and neutropenia in patients with cancer. It is not yet known whether moxifloxacin alone is more effective than amoxicillin combined with ciprofloxacin in treating neutropenia and fever. PURPOSE: This randomized clinical trial is studying how well moxifloxacin works and compares it to ciprofloxacin together with amoxicillin in treating neutropenia and fever in patients with cancer.
NCT00082173 Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis Completed Johns Hopkins University Phase 2 Current treatment of tuberculosis (TB) requires patients to take four drugs for 8 weeks and then two drugs for 4 months. New drug regimens that are shorter and effective against drug-resistant TB are needed. This study will evaluate whether using the drug moxifloxacin (MOX) in place of ethambutol (EMB) during the first 8 weeks of treatment will effectively treat TB.
NCT00140309 TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment Completed Centers for Disease Control and Prevention Phase 2 This study is a placebo-controlled factorial study, randomized to study drug (moxifloxacin vs. ethambutol) and treatment frequency (daily vs. thrice weekly after an initial two weeks of daily therapy) during the first two months of standard treatment (with isoniazid, rifampin, and pyrazinamide) for sputum smear-positive pulmonary tuberculosis.
NCT00144417 TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment Completed Bayer Phase 2 This double-blind, randomized controlled trial evaluates moxifloxacin versus isoniazid in daily treatment during the first two months of treatment with rifampin, pyrazinamide and ethambutol for sputum smear-positive pulmonary tuberculosis.
NCT00144417 TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment Completed Global Alliance for TB Drug Development Phase 2 This double-blind, randomized controlled trial evaluates moxifloxacin versus isoniazid in daily treatment during the first two months of treatment with rifampin, pyrazinamide and ethambutol for sputum smear-positive pulmonary tuberculosis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container

Condition Name

Condition Name for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Intervention Trials
Healthy 53
Tuberculosis 16
Healthy Subjects 12
Healthy Volunteers 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Intervention Trials
Tuberculosis 35
Pneumonia 19
Infection 15
Communicable Diseases 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container

Trials by Country

Trials by Country for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Location Trials
United States 338
Germany 84
South Africa 79
United Kingdom 46
China 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Location Trials
Texas 33
California 23
Florida 19
New York 17
Maryland 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Clinical Trial Phase Trials
Phase 4 36
Phase 3 49
Phase 2/Phase 3 2
[disabled in preview] 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Clinical Trial Phase Trials
Completed 212
Recruiting 29
Unknown status 17
[disabled in preview] 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container

Sponsor Name

Sponsor Name for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Sponsor Trials
Bayer 31
GlaxoSmithKline 19
AstraZeneca 15
[disabled in preview] 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Moxifloxacin Hydrochloride In Sodium Chloride 0.8% In Plastic Container
Sponsor Trials
Industry 237
Other 209
U.S. Fed 12
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Healthtrust
McKinsey
Daiichi Sankyo
Fuji
Cantor Fitzgerald
Covington
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.